AbbVie Inc. (ABBV) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $5.83B2017: $7.04B2018: $7.72B2019: $7.44B2020: $15.39B2021: $17.45B2022: $17.41B2023: $20.41B2024: $16.90B2025: $18.20B$18.20B
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$18.20B+7.7%
2024$16.90B-17.2%
2023$20.41B+17.2%
2022$17.41B-0.2%
2021$17.45B+13.4%
2020$15.39B+106.8%
2019$7.44B-3.6%
2018$7.72B+9.6%
2017$7.04B+20.7%
2016$5.83B